Skip to content

NAD+evidence-first

The NAD Review
menu

provider_review · verified 2026-07-31

Try Ageless review

An open FDA letter, and no advertised figure the seller calls final

The FDA issued a warning letter in September 2025 to Lovely Meds, Inc. dba Lovely Meds — the entity Try Ageless's own regulation page names as operating tryageless.com — and the index does not record it as closed out; separately, $249 is the list, $199 is an intro-code rate, and the page itself says the real amount is set after clinical review.

How this site makes money

Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.

FDA warning letter. The FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds in September 2025. The agency's index does not record it as closed out. You can look it up on the FDA’s warning-letter index.

at_a_glance

price
NAD+ listed at $249/month, advertised at $199 with an introductory code, alongside the site's own statement that the final amount is set after clinical review.
what you pay
Not determinable from the public site. The seller states the amount is set after clinical review, so $199 and $249 are both provisional.
pharmacy
Seven are named — The Pharmacy Hub LLC, Greenwich Rx, VialsRX, Partell Specialty, Believe Rx, Precision Compounding Pharmacy & Wellness and HealthWarehouse.com — which is the longest pharmacy list on this index. None carries a published 503A or 503B designation. Two clinicians are named and both check out in the national registry: Michael Wasef MD (NPI 1417261926, internal medicine, Florida) and Jonah Mink MD (NPI 1083052351). Against that, its `/medical-experts/` page is unedited template filler — one name appears twice under two different specialties, and the testimonials carry stock UI-kit names.
states
Not published — no list exists anywhere on the site. Its own peptide page claims "State-smart — We tell you what's available in your state upfront". It does not.
on our index
Ranked #11 of 50 on our NAD+ provider index.

verdict

The short version

Start with the fact that decides whether the rest matters. In September 2025 the FDA issued a warning letter to Lovely Meds, Inc. dba Lovely Meds — and that is not a name resemblance: Try Ageless's own `/medical-experts-regulation/` page states that "Try Ageless is a brand operated by Lovely Meds, Inc. The website tryageless.com is managed under this entity." The agency's index does not record the letter as closed out. We link to this company, we are paid when a reader starts care through that link, and we have kept the link — so you are getting the letter in the same breath as the listing. On the commercial side: Try Ageless sells compounded NAD+ as an injection and as a troche, inside a broader longevity and weight-loss menu. It is credited here for one unusual admission: the site states that the final amount is determined after clinical review, which is more honest than the competitors who let an intro rate stand as though it were the price. The consequence, though, is that nothing it advertises is a price. $249 is the list, $199 is what an introductory code produces, and the number you pay is decided later. Add a second structure — Try Ageless runs a shop with per-dose pricing alongside a plan funnel with different figures for the same molecule — and comparison-shopping it is close to impossible from the outside.

evidence

What the evidence for this route shows

Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. The troche is worth a separate note: a buccal or sublingual troche is neither an injection nor a capsule, and there is no human study showing that buccal NAD+ raises blood NAD+ either. "Needle-free" is a convenience claim, not an absorption one.

pricing

What it actually costs

advertised
NAD+ listed at $249/month, advertised at $199 with an introductory code, alongside the site's own statement that the final amount is set after clinical review.
you pay
Not determinable from the public site. The seller states the amount is set after clinical review, so $199 and $249 are both provisional.
the catch
Introductory-code pricing on top of a list price, with the real figure deferred to after intake. Try Ageless also runs two parallel price structures on the same brand — a shop with standing per-dose prices and a separate plan-based funnel with its own, higher month-to-month rates that fall on longer commitments — so which number applies depends on which door you came through.

Other money you will meet

  • The introductory code applies to a first order, not to the standing rate
  • No membership fee is published

source :: read at tryageless.com on 2026-07-31, in a browser that runs JavaScript.

fit

Who this is and is not for

Buy it if

  • You want a troche rather than an injection and cannot find one elsewhere
  • You want NAD+ inside a broader longevity menu from one provider
  • You are comfortable discovering your actual price during clinical review

Look elsewhere if

  • You want to budget before you start — no published figure here is final by the seller's own statement
  • You want one price structure: the shop and the plan funnel price the same products differently
  • You want a named pharmacy or a 503A/503B designation
  • You want to compare against this site's other providers on a like-for-like number

included

What is inside the price

consult
Yes — clinical review precedes dispensing, and the site states the final price is set at that point.
labs
Optional; no lab gate is published for the NAD+ line.
follow-ups
Not published for the NAD+ line.
human support
No dietitian or coaching program is part of the offer.
supplies
Not itemized publicly for the injection.
shipping
Not itemized publicly for the NAD+ line.

the_knock

What they would rather you skipped

The FDA issued a warning letter in September 2025 to Lovely Meds, Inc. dba Lovely Meds, the entity Try Ageless's own regulation page names as the operator of tryageless.com, and the agency's index does not record it as closed out. We are not going to characterize the agency's case here — the letter is public and makes it better than a paraphrase of ours would — but its existence, its date and its open status are not optional information for someone about to hand this company a payment and a medical history. Our own screening nearly missed it, and how it did is worth writing down: the FDA index returns nothing for "tryageless" and nothing for "lovelymeds" run together. The letter appears only under the spaced firm name "Lovely Meds", which is a name the storefront never uses. That was our failure, not the company's, and it is recorded in our code so the next screen runs against the whole enforcement list rather than one brand token at a time. Two more things, and the second is part of why this row sits last of our partners. First: by Try Ageless's own account no published figure is the price, which means every number on its marketing pages is an advertisement rather than an offer. Second, and more practically for anyone trying to check us — the site returns HTTP 403 to an automated browser. We could not read it ourselves on this pass; the figures above come from a manual rendered check by our editor the same day, and that is a weaker receipt than the live URL we can hand you for every other provider here. A price-transparency index has to be able to say where it looked, and here we can point you at a door that may not open for you either. Readers should also note that Try Ageless (tryageless.com) is a completely different company from AgelessRx (agelessrx.com), which appears separately on our index. They are not affiliated and their pricing has nothing to do with one another.

And the rest

  • An FDA warning letter issued in September 2025 to Lovely Meds, Inc. dba Lovely Meds — the entity Try Ageless's own regulation page names as operating tryageless.com — sits on the agency's public record, and its close-out column is empty
  • Its LegitScript seal does not currently resolve: the badge in its footer returns an error while a known-good seal returns an image in the same check, so we do not describe Try Ageless as LegitScript certified
  • The seller states the final amount is set after clinical review, so no advertised figure is binding
  • Two parallel price structures — a per-dose shop and a plan funnel — for the same products
  • The public site blocks automated readers, so independent verification is harder than for any other row
  • Seven pharmacies are named but none is categorized 503A or 503B, and no state list is published anywhere
  • Try Ageless pays us a commission if you start care through this page

tools

Work out your own number

visit Try Ageless

Every figure on this page was read on Try Ageless’s own site on 2026-07-31 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.